Intangible capital in the pharmaceutical chemical industry;.pdfVIP

University of New Orleans ScholarWorks@UNO Department of Economics and Finance Working Department of Economics and Finance Papers, 1991-2006 1-1-2003 Intangible capital in the pharmaceutical chemical industry; Katherine I. Gleason University of N ew Orleans Mark Klock George Washing ton University Follow this and additional works at : /econ_wp Recommended Citation Gleason, Katherine I. and Klock, Mark, Intangible capital in the pharmaceutical chemical industry; (2003). Department of Economics and Finance Working Pap ers, 1991-2006. Paper 10. /econ_wp/10 This Working Paper is brought to you for free and open access by the Department of Economics and Finance at ScholarWorks@UNO. It has been accepted for inclusion in Department of Economics and Finance Working Papers, 1991-2006 by an authorized administrator of ScholarWorks@UNO. For more information, please contact scholarworks@. February 2003 Intangible Capital in the Pharmaceutical Chemical Industry Katherine I. Gleason* ** Mark Klock contact: klock@ (202)994-8342 fax: (202)994-5014 *Assistant Professor of Finance, University of New Orleans, New Orleans, LA 70148 ** Professor of Finance, George Washington University, Washington, D.C. 20052 Abstract We investigate whether measures of intangible capital based on advertising and RD can explain variation in Tobin’s Q ratio for the pharmaceutical chemical industry using data from 1982 to 2001. The study is motivated by prior literature studying this relation in other